162 related articles for article (PubMed ID: 33911478)
1. Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with
Suh MS; Choi YD; Lee JB; Lee SC; Won YH; Yun SJ
Ann Dermatol; 2018 Oct; 30(5):556-561. PubMed ID: 33911478
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival.
Ito T; Kaku-Ito Y; Murata M; Furue K; Shen CH; Oda Y; Furue M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32143442
[TBL] [Abstract][Full Text] [Related]
3. Intra- and Inter-Tumor
Ito T; Kaku-Ito Y; Murata M; Ichiki T; Kuma Y; Tanaka Y; Ide T; Ohno F; Wada-Ohno M; Yamada Y; Oda Y; Furue M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817947
[TBL] [Abstract][Full Text] [Related]
4. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
Lyu JJ; Kong YY; Cai X; Shen XX; Lu YW; Ren M
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):548-552. PubMed ID: 28810295
[No Abstract] [Full Text] [Related]
5. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
6. Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.
Pearlstein MV; Zedek DC; Ollila DW; Treece A; Gulley ML; Groben PA; Thomas NE
J Cutan Pathol; 2014 Sep; 41(9):724-32. PubMed ID: 24917033
[TBL] [Abstract][Full Text] [Related]
7. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
Estrella JS; Tetzlaff MT; Bassett RL; Patel KP; Williams MD; Curry JL; Rashid A; Hamilton SR; Broaddus RR
Mol Cancer Ther; 2015 Dec; 14(12):2887-95. PubMed ID: 26438153
[TBL] [Abstract][Full Text] [Related]
8. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
Huang WK; Kuo TT; Wu CE; Cheng HY; Hsieh CH; Hsieh JJ; Shen YC; Hou MM; Hsu T; Chang JW
Asia Pac J Clin Oncol; 2016 Dec; 12(4):403-408. PubMed ID: 27488807
[TBL] [Abstract][Full Text] [Related]
9. Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.
Caliò A; Eble JN; Hes O; Martignoni G; Harari SE; Williamson SR; Brunelli M; Osunkoya AO; Wang L; Comperat E; Lopez-Beltran A; Wang M; Zhang S; Curless KL; Post KM; Chang HY; Luchini C; Baldrige LA; MacLennan GT; Montironi R; Grignon DJ; Cheng L
Oncotarget; 2017 Aug; 8(33):54096-54105. PubMed ID: 28903326
[No Abstract] [Full Text] [Related]
10. Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.
Liu H; Li Z; Wang Y; Feng Q; Si L; Cui C; Guo J; Xue W
Pathol Int; 2014 Dec; 64(12):601-6. PubMed ID: 25359093
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
Dvorak K; Higgins A; Palting J; Cohen M; Brunhoeber P
Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628
[TBL] [Abstract][Full Text] [Related]
12. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
15. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
Capper D; Preusser M; Habel A; Sahm F; Ackermann U; Schindler G; Pusch S; Mechtersheimer G; Zentgraf H; von Deimling A
Acta Neuropathol; 2011 Jul; 122(1):11-9. PubMed ID: 21638088
[TBL] [Abstract][Full Text] [Related]
16. BRAF Mutation Analysis in Primary Acral Melanoma of 41 Cases from South of Iran.
Sari Aslani F; Safaee A; Akbarzadeh Jahromi M; Karami L
Iran J Pathol; 2021; 16(4):370-375. PubMed ID: 34567185
[TBL] [Abstract][Full Text] [Related]
17. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression profiles of BRAF (V600E/VE1) in serrated colon polyps in Turkish population.
Kokenek-Unal TD; Senel F; Gurcay N; Tasdemir A; Coban I
Int J Clin Exp Pathol; 2017; 10(8):8868-8874. PubMed ID: 31966754
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
20. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
